Parameter
| Biomarker | Prevotella | Full name | Prevotella spp. | Molecular Type | Microbes |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, prognosis, immunomodulation | ||
| Disease | Esophageal Carcinoma | Disease Subtypes | / | ||
| Organ | Esophagus | Test Sample / Technology Platform | Esophageal tissue/stool (16S rRNA sequencing, qPCR) | ||
| Pathobiological Mechanisms | Some subtype abundance anomalies associated with ESCC progress, by adjusting the indoles metabolites such as tumor microenvironment, to participate in the process of immunosuppression | ||||
| Clinical Availability Status | Clinical research stage: It has been frequently identified in ESCC microbiota studies with good diagnostic specificity | ||||
| Notes and Dynamics | The dual role of ESCC microbiota (cancer-promoting and cancer-suppressing in some subtypes) needs to be further clarified to provide a basis for precise targeting of microbiota | ||||